Stay updated on Copanlisib and Nivolumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Copanlisib and Nivolumab in Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The two screenshots show no changes to core study information (title, NCT03484819, sponsor, eligibility criteria, interventions, and locations) and no new sections or data appear. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:34:04.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    - Added a government funding notice and operating status guidance, and updated the version to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T12:51:14.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated page to version v3.1.0 and removed the topic 'Diffuse large B-cell lymphoma' from resources; this reduces a core topic from the content.
    Difference
    0.3%
    Check dated 2025-09-28T09:33:10.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Updated core revision from v3.0.1 to v3.0.2; the Back to Top element was removed. No other substantive changes to pricing, stock, times, or proper nouns.
    Difference
    0.1%
    Check dated 2025-09-14T00:10:23.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T17:53:10.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on diffuse large B-cell lymphoma and related medical topics. Notably, previous mentions of certain diseases and agents have been removed.
    Difference
    2%
    Check dated 2025-08-30T15:17:50.000Z thumbnail image

Stay in the know with updates to Copanlisib and Nivolumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.